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Metabolic syndrome can result from obesity that is a growing public health concern. Propionate is a 
major fermentation product in our gut with several health benefits towards energy homeostasis. For 
instance, propionate is able to stimulate satiety-inducing hormones leading to lower energy intake and 
thus weight loss. In this study, the effect of a consortium of Lactobacillus plantarum, Bacteroides 
thetaiotaomicron, Ruminococcus obeum, Coprococcus catus, Bacteroides vulgatus, Akkermansia 
muciniphila, Veillonella parvula was studied for its potential to increase propionate concentrations in 
vitro. The mucosal simulator of the human intestinal microbial ecosystem (M-SHIME) was used to 
assess the total short chain fatty acid (SCFAs) and propionate production, as indicators of gut 
microbial functionality. Clindamycin was used to trigger  dysbiosis, and the addition of the propionate-
producing community aimed at raising the propionate levels in the in vitro system. SCFA was 
measured using gas chromatography method. Moreover, the effect of the consortium was assessed in 
the epithelial barrier function, membrane potential and mitochondrial activity in a triple co-culture 
model of Caco2, Ht29-MTX and HepG2 cells. Addition of the microbial consortium promoted recovery 
of the propionate levels following the supplementation with clindamycin, in comparison with controls. 
This consortium also showed a positive effect on epithelial barrier function, membrane potential and 
mitochondrial activity compared to the controls when it metabolites were not added on the cells. Our 
results indicate that, for a successful outcome, the next generation of “smart” probiotics must be 
designed taking into account the metabolic interactions among the members of the probiotic 
community.   
 
